Annual Epidemiological Report 2009 [2007 data]
This edition of the Annual Report gives special attention to vaccine-preventable diseases and immunisation programmesin the European Union (EU) and European Economic Area (EEA) countries. This edition was revised January and June 2010 and has authority over the print edition.
- Antimicrobial resistance
- Avian influenza virus
- Emerging disease
- Food- and waterborne diseases
- Healthcare-associated infections
- HIV infection
- Influenza in humans, avian origin
- Influenza in humans, seasonal
- Sexually transmitted infections
- Vaccine preventable diseases
- Vector-borne disease
Rapid risk assessment: Carbapenem-resistant Acinetobacter baumannii in healthcare settings – 8 December 2016
This risk assessment provides an overview of the epidemiological situation in Europe and describes a number of response options.
Rapid risk assessment: Regional outbreak of New Delhi metallo-betalactamase-producing carbapenem-resistant Enterobacteriaceae, Italy, 2018–2019
A large outbreak of New Delhi metallo-beta-lactamase (NDM)-producing carbapenem-resistant Enterobacteriaceae (CRE) has been reported from the Tuscany region in Italy. Between November 2018 and May 2019, seven Tuscan hospitals notified a total of 350 cases.
Rapid risk assessment: Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 in travellers previously hospitalised in Gran Canaria, Spain
This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.
Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae - first update
This update of the 2016 ECDC Rapid Risk Assessment on carbapenem-resistant Enterobacteriaceae (CRE) evaluates the risk for patients and healthcare systems in EU/EEA countries due to the global spread of CRE.
Annual Epidemiological Report on Communicable Diseases in Europe 2007 [2005 data]
Annual Epidemiological Report on Communicable Diseases in Europe 2007
Annual Epidemiological Report on communicable diseases in Europe 2007 - Executive Summary [2005 data]
Annual Epidemiological Report on communicable diseases in Europe 2007 - Executive Summary
ECDC country visit to Norway to discuss antimicrobial resistance issues
An ECDC country visit team conducted an assessment mission during the period 12–16 March 2018 to discuss antimicrobial resistance (AMR) issues in Norway. The overall objective of the mission was to provide an observation-based assessment of the situation in Norway regarding prevention and control of AMR through prudent use of antibiotics and infection control.
Rapid risk assessment: Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae
This risk assessment will discuss CAZ-AVI resistance in brief, review the recent literature reporting resistance of CRE to CAZ-AVI, and assess the risk for the EU/EEA countries.
Communicable disease threats report, 17-23 May 2015, week 21
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 May 2015, and includes updates on Salmonella Enteritidis, influenza, Mycobacterium chimaera, Ebola virus, MERS, avian influenza and polio.